Konety BR - Search Results

1

Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members.

Matulay JT, Tabayoyong W, Duplisea JJ, Chang C, Daneshmand S, Gore JL, Holzbeierlein JM, Karsh LI, Kim SP, Konety BR, Li R, McKiernan JM, Messing EM, Steinberg GD, Williams SB, Kamat AM. Matulay JT, et al. Among authors: konety br. Urol Oncol. 2020 Oct;38(10):796.e1-796.e6. doi: 10.1016/j.urolonc.2020.04.026. Epub 2020 May 17. Urol Oncol. 2020. PMID: 32430255

2

Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis.

Joudi FN, Smith BJ, O'Donnell MA, Konety BR. Joudi FN, et al. Among authors: konety br. Urology. 2003 Dec;62(6):1083-8. doi: 10.1016/s0090-4295(03)00765-9. Urology. 2003. PMID: 14665360

3

Molecular markers in bladder cancer: a critical appraisal.

Konety BR. Konety BR. Urol Oncol. 2006 Jul-Aug;24(4):326-37. doi: 10.1016/j.urolonc.2005.11.023. Urol Oncol. 2006. PMID: 16818187 Review.

4

Complete response of bony metastatic bladder urothelial cancer to neoadjuvant chemotherapy and cystectomy.

Joudi FN, Dahmoush L, Spector DM, Konety BR. Joudi FN, et al. Among authors: konety br. Urol Oncol. 2006 Sep-Oct;24(5):403-6. doi: 10.1016/j.urolonc.2005.12.002. Urol Oncol. 2006. PMID: 16962489

5

The impact of marriage on bladder cancer mortality.

Nelles JL, Joseph SA, Konety BR. Nelles JL, et al. Among authors: konety br. Urol Oncol. 2009 May-Jun;27(3):263-7. doi: 10.1016/j.urolonc.2008.04.016. Epub 2008 Jul 14. Urol Oncol. 2009. PMID: 18625568

6

Optimizing outcomes at every stage of bladder cancer: do we practice it?

Herr H, Konety B, Stein J, Sternberg CN, Wood DP Jr. Herr H, et al. Urol Oncol. 2009 Jan-Feb;27(1):72-4. doi: 10.1016/j.urolonc.2008.06.005. Urol Oncol. 2009. PMID: 19111802 Review.

7

Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer.

Breyer BN, Whitson JM, Carroll PR, Konety BR. Breyer BN, et al. Among authors: konety br. Urol Oncol. 2010 Sep-Oct;28(5):510-4. doi: 10.1016/j.urolonc.2008.11.019. Epub 2009 Jan 26. Urol Oncol. 2010. PMID: 19171491 Free PMC article.

8

Candidate quality of care indicators for localized bladder cancer.

Cooperberg MR, Porter MP, Konety BR. Cooperberg MR, et al. Among authors: konety br. Urol Oncol. 2009 Jul-Aug;27(4):435-42. doi: 10.1016/j.urolonc.2009.01.012. Urol Oncol. 2009. PMID: 19573775 Free article. Review.

9

Compliance with guidelines for patients with bladder cancer: variation in the delivery of care.

Chamie K, Saigal CS, Lai J, Hanley JM, Setodji CM, Konety BR, Litwin MS; Urologic Diseases in America Project. Chamie K, et al. Among authors: konety br. Cancer. 2011 Dec 1;117(23):5392-401. doi: 10.1002/cncr.26198. Epub 2011 Jul 11. Cancer. 2011. PMID: 21780079 Free PMC article.

10

Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non-muscle invasive bladder cancer.

Lightfoot AJ, Breyer BN, Rosevear HM, Erickson BA, Konety BR, O'Donnell MA. Lightfoot AJ, et al. Among authors: konety br. Urol Oncol. 2014 Jan;32(1):35.e15-9. doi: 10.1016/j.urolonc.2013.01.009. Epub 2013 Mar 17. Urol Oncol. 2014. PMID: 23510863 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters